Where Global Innovation
and Capital Meet

Strand Therapeutics attaches $52m

Jun 24, 2021 • Robert Lavine

MIT mRNA therapeutics spinout Strand has secured series A funding from BeiGene, Redmile Group, Camford Capital, Playground Global and Anri.

Strand Therapeutics, a US-based messenger RNA (mRNA) drug developer spun out of Massachusetts Institute of Technology (MIT), secured $52m in series A funding yesterday.
Biopharmaceutical company BeiGene provided the cash along with hedge fund manager Redmile Group and venture capital firms Camford Capital, Playground Global and Anri.
Founded in 2017, Strand is working on mRNA drugs to treat cancer and other diseases by acting through several mechanisms to attack solid tumours while reducing toxicity to the rests of…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

Robert Lavine

Robert Lavine is special features editor for Global Venturing.

Linked in

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

University of Notre Dame tries new, supersized approach to creating spinouts

A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.

University of Tokyo investment arm forms deeptech fund

University of Tokyo’s third investment fund reached a first close with capital from Tokyu Land and the Tokyo Metropolitan Government.

New fund to target University of Arkansas startups

Venture firm 46VC’s Dickson & Main Fund I will invest in companies associated with the university or the local Arkansas ecosystem.

Events

GCV Institute: Landing the Value of Corporate Venturing

May 6 -
May 9, 2024
Online

Find out more All events

Events

Webinar: CVCs and the art of the follow-on

May 8, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

May 21 -
May 22, 2024
Online

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.